Recent advancements in tension-type headache: a narrative review

Expert Rev Neurother. 2021 Jul;21(7):793-803. doi: 10.1080/14737175.2021.1943363. Epub 2021 Jul 2.

Abstract

Introduction: Tension-type headache (TTH) is the most common primary headache disorder with a prevalence of up to 78% in general population and huge expenses in terms of health service. Despite its high incidence and impact on life's quality the knowledge on the pathophysiology and efficacious treatment of TTH was still limited.

Areas covered: In recent years, a series of studies highlighted the heterogeneous nature of this pathology that seems to be determined by a complex interaction between genetic, environmental, and neuromuscular factors, which result in nociceptive system activation. In this setting, alongside the simple analgesic therapies used during the acute attack, a series of therapeutic options based on newly acquired experiences have taken hold.

Expert review: Not having a single substrate or a typical site of pathophysiology, TTH must be analyzed in a global and multidisciplinary way. Herein, we perform a narrative review of the most recent advancement stimulating the concept of this disease as the tip of the iceberg of a more complex individual malaise secondary to different alterations. Strategies based solely on symptomatic drugs should therefore be avoided by experienced personnel and treatment should aim at taking charge of the patient considering the processes behind this complex pathology.

Keywords: Tension-type headache; alternative medicine; comorbidities; pathogenesis; psychopathology; treatment.

Publication types

  • Review

MeSH terms

  • Analgesics
  • Humans
  • Prevalence
  • Tension-Type Headache* / therapy
  • Treatment Outcome

Substances

  • Analgesics